DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The REMEDY Act amends the Federal Food, Drug, and Cosmetic Act to restrict patent-related delays in the approval of generic drugs (abbreviated new drug applications). For drugs approved after the bill's enactment, it requires applicants to designate a single "covered patent" eligible for a 30-month stay of generic approval, preventing the use of multiple patents to extend market exclusivity. The bill applies this restriction prospectively while preserving existing rules for previously approved drugs.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.